Advanced orthopedic market seen reaching $98.14 billion by 2030

The Business Research Company says the global market for advanced orthopedic technologies, implants and regenerative products will grow from $74.2 billion in 2026 to $98.14 billion by 2030. The report points to sports injuries, robotic surgery, patient-specific implants and regenerative therapies as major growth drivers.

Why it matters: - Advanced orthopedic technologies, implants and regenerative products support recovery for patients with musculoskeletal conditions. - The market’s expected expansion signals rising demand for joint replacement, tissue repair and other orthopedic procedures. - Growth in this category also tracks broader adoption of robotics, biologics and personalized care in orthopedics.

What happened: - The Business Research Company released a market report on advanced orthopedic technologies, implants and regenerative products on July 23, 2026. - The report projects the market will rise from $69.58 billion in 2025 to $74.2 billion in 2026. - The market is forecast to reach $98.14 billion by 2030. - The report covers global market size, trends and forecasts for 2026-2035. - A free sample is available here. - The full report is available here.

The details: - The report says the market grew on the back of rising musculoskeletal disorders, more orthopedic surgeries, better implant materials, specialty clinics and improved access to joint replacement procedures. - The report forecasts a 6.6% CAGR in the historical period and a 7.2% CAGR through 2030. - Demand is being driven by patient-specific implants, wider use of biologic therapies, higher investment in regenerative medicine research, more robotic-assisted surgeries and better long-term implant performance. - Anticipated trends include regenerative therapies, smart implants, minimally invasive procedures and more personalized orthopedic care. - The report defines advanced orthopedic technologies as devices and therapies that improve mobility, support tissue regeneration and speed healing. - The report also highlights sports-related injuries as a major growth driver. - U.S. National Safety Council data cited in the release shows sports and recreational injuries increased to 564,845 cases in 2024 from 482,886 in 2023. - In 2025, North America held the largest share of the market. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The forecast suggests orthopedics is shifting from standardized implants toward more customized and data-enabled treatment options. - Sports injuries are adding near-term pressure to the market, while regenerative medicine and robotics point to longer-term structural change. - North America’s current lead and Asia-Pacific’s projected growth suggest the category remains mature in developed markets but still has room to expand quickly in emerging ones.

What's next: - The market’s next phase will likely hinge on how quickly hospitals and surgeons adopt robotics, smart implants and biologic therapies. - Investors and suppliers will watch whether regenerative products move from niche use toward broader orthopedic practice. - Regional growth will depend on reimbursement, surgical capacity and access to advanced procedures.

The bottom line: - The orthopedic technologies market is expanding steadily, with the strongest upside coming from personalized implants, regenerative care and robotic-assisted surgery.